10.1371/journal.pone.0147951.s001 Anna K. Kraus Anna K. Kraus Jin Chen Jin Chen Ilka Edenhofer Ilka Edenhofer Inga Ravens Inga Ravens Ariana Gaspert Ariana Gaspert Pietro E. CippĂ  Pietro E. CippĂ  Steffen Mueller Steffen Mueller Rudolf P. Wuthrich Rudolf P. Wuthrich Stephan Segerer Stephan Segerer Guenter Bernhardt Guenter Bernhardt Thomas Fehr Thomas Fehr Absence of DNAM-1 ligands does not prolong skin allograft survival. Public Library of Science 2016 ligands CD 112 T Cell Costimulation CD 155 CD 112 Kidney Transplantation DNAX accessory protein mouse kidney transplantation model DNAM allospecific T cell response 2016-02-03 22:27:20 Figure https://plos.figshare.com/articles/figure/The_Role_of_T_Cell_Costimulation_via_DNAM_1_in_Kidney_Transplantation/2607247 <p>(A) Skin grafts from fully MHC-mismatched WT BALB/c (n = 19) or CD155 KO (n = 24) donors were performed on B6 recipients. Median survival time: 9 vs. 10 days (WT vs. CD155 KO). (B) Skin grafts from WT BALB/c (n = 7) or CD155 KO (n = 8) donors were performed on minor antigen mismatched DBA/2 recipients. Median survival time: 13 vs. 15 days (WT vs. CD155 KO). (C) Skin grafts from fully MHC-mismatched WT B6 (n = 8) or CD112 KO (n = 8) donors were performed on CBA recipients. Median survival time: 11 vs. 12 days (WT vs. CD112 KO). (D) Skin grafts from MHC I antigen mismatched B6 (n = 7) or CD112 (n = 8) donors were performed on bm1 recipients. Median survival time: 25.5 vs. 21 days (WT vs. CD112 KO, P = 0.01).</p> <p>(TIF)</p>